Gordon P. Watt, Isela De La Cerda, Jen‐Jung Pan, Michael B. Fallon, Laura Beretta, Rohit Loomba, Miryoung Lee, Joseph B. McCormick, Susan P. Fisher‐Hoch – 31 October 2020 – Diabetes is associated with liver disease and risk of hepatocellular carcinoma. In this study, we evaluated the association between liver fibrosis measured by transient elastography and four glucose metabolism measures in the Cameron County Hispanic Cohort, a population‐based, randomly selected cohort of Mexican American Hispanics with high rates of diabetes and liver cancer.

Chathur Acharya, Jasmohan S. Bajaj – 31 October 2020

Michelle T. Long, Xiaoyu Zhang, Hanfei Xu, Ching‐Ti Liu, Kathleen E. Corey, Raymond T. Chung, Rohit Loomba, Emelia J. Benjamin – 30 October 2020

Jean C. Emond – 30 October 2020

Juanjuan Zhao, Fengyun Chu, Hualin Xu, Mengmeng Guo, Shan Shan, Wen Zheng, Yijing Tao, Ya Zhou, Yan Hu, Chao Chen, Tao Ren, Lin Xu – 30 October 2020

Nadim Mahmud, David S. Goldberg, David E. Kaplan, Marina Serper – 29 October 2020

Eric Kauffman‐Ortega, Jesus Ruiz‐Manriquez, Antonio Olivas‐Martinez, Alejandro Campos‐Murguia, Ernesto Marquez‐Guillen, Nayelli Flores‐Garcia, Mario Vilatoba, Alan Contreras‐Saldivar, Ignacio García‐Juárez – 28 October 2020

Angeline Yasodhara, Victor Dong, Amirhossein Azhie, Anna Goldenberg, Mamatha Bhat – 28 October 2020 – Diabetes mellitus (DM) significantly impacts long‐term survival after liver transplantation (LT). We identified survival factors for LT recipients who had DM to inform preventive care using machine‐learning analysis. We analyzed risk factors for mortality in patients from across the United States using the Scientific Registry of Transplant Recipients (SRTR). Patients had undergone LT from 1987 to 2019, with a follow‐up of 6.47 years (standard deviation [SD] 5.95).

Elizabeth M. Brunt, David E. Kleiner, Danielle H. Carpenter, Mary Rinella, Stephen A. Harrison, Rohit Loomba, Zobair Younossi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, for the American Association for the Study of Liver Diseases NASH Task Force – 27 October 2020 – The role of liver biopsy in NASH has evolved along with the increased recognition of the significance of this disease, and the unmet medical need it presents. Drug development and clinical trials are rapidly growing, as are noninvasive tests for markers of steatosis, inflammation, injury, and fibrosis.

Daisuke Noguchi, Naohisa Kuriyama, Taemi Hibi, Koki Maeda, Toru Shinkai, Kazuyuki Gyoten, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Akihiro Tanemura, Yasuhiro Murata, Masashi Kishiwada, Hiroyuki Sakurai, Shugo Mizuno – 27 October 2020 – Thrombin is a key player in the coagulation cascade, and it is attracting much attention as a promotor of cellular injured signaling. In ischemia/reperfusion injury (IRI), which is a severe complication of liver transplantation, thrombin may also promote tissue damage.